Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Journal of Neural Transmission. General Section|January 1, 1994
Glycine site antagonists abolish dopamine D2 but not D1 receptor mediated catalepsy in ratsB D Kretschmer, B Winterscheid, W Danysz, et al.
European Journal of Pharmacology|December 8, 1992
Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in ratsM Bubser, U Keseberg, P K Notz, et al.
Amino Acids|November 7, 2013
Anticataleptic potencies of glutamate-antagonistsW J Schmidt, B Zadow, B D Kretschmer, et al.
Behavioural Brain Research|December 7, 2010
The role of NMDA and AMPA/Kainate receptors in the consolidation of catalepsy sensitizationK Riedinger, A Kulak, W J Schmidt, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 18, 2003
Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent?H B Lebsanft, A Mayerhofer, K-A Kovar, et al.
Behavioural Pharmacology|March 16, 2005
Effects of mGlu1 and mGlu5 receptor antagonists on negatively reinforced learningA Gravius, M Pietraszek, D Schäfer, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1995
Effect of coadministration of glutamate receptor antagonists and dopaminergic agonists on locomotion in monoamine-depleted ratsM Gossel, W J Schmidt, W Löscher, et al.
Chemico-Biological Interactions|February 1, 1992
Limitations of the in vitro repair synthesis assay for probing the role of DNA repair in platinum resistanceA F Nichols, W J Schmidt, S G Chaney, et al.
Neuroscience and Biobehavioral Reviews|July 1, 1997
Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studiesW Danysz, C G Parsons, J Kornhuber, et al.
Pageof 10